On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Home > Blog
MondayNov 03, 2008 4:36 am

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX)

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), an integrated biopharmaceutical company, utilizes crystallography and structure-based drug design to develop a deep pipeline of innovative therapeutics. Currently, the company is progressing investigational new drugs discovered in-house in late-stage clinical trials for influenza and lymphoma. The U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross Corporation and Mundipharma International Holdings Ltd. have all formed strategic alliances with the company and validate its scientific foundation and the utility of its product candidates. For further information, visit the Company's web site at www.biocryst.com .

Continue Reading

MondayNov 03, 2008 4:36 am

Oncolytics Biotech, Inc. (NASDAQ: ONCY)

Oncolytics Biotech, Inc. (NASDAQ: ONCY) has focused their efforts on the discovery and development of pharmaceutical products designed to treat of a broad range of human cancers. With headquarters in Calgary, Alberta, Canada, the Company was formed in 1998 to investigate the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, which happens to be one of the most common families of genetic defects leading to cancer. For further information, visit the Company's web site at www.oncolytics.com.

Continue Reading

MondayNov 03, 2008 4:35 am

Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI)

Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI) is dedicated to developing innovative technologies that provide safer and more effective options to patients in areas with significant, but unmet medical needs. The company is primarily focused on the areas of biosurgical and passive immunotherapy products. By utilizing their proprietary protein purification technology, novel development capabilities, and manufacturing expertise, the company aims to develop treatments of choice in their respective therapeutic areas. For further information, visit the Company's web site at www.omrix.com.

Continue Reading

MondayNov 03, 2008 4:35 am

Bio-Bridge Science, Inc. (OTC BB: BGES)

Bio-Bridge Science, Inc. (OTC BB: BGES) is a development stage biotechnology company committed to engaging in the commercial development of vaccines for the prevention and treatment of human infectious diseases. Currently, the company is focused on developing and commercializing HIV-PV Vaccine I to prevent and treat infection by the human immunodeficiency virus (HIV). The HIV vaccines developed by Bio-Bridge are designed for both preventive and therapeutic purposes. For further information, visit the Company's web site at www.bio-bridge-science.com.

Continue Reading

MondayNov 03, 2008 4:35 am

OMNI Energy Services Corp. (NASDAQ: OMNI)

OMNI Energy Services Corp. (NASDAQ: OMNI), an integrated oilfield service company, specializes in providing a range of onshore seismic drilling, operational support, permitting, and survey services to geophysical companies operating in logistically difficult and environmentally sensitive terrain. The company also provides dock-side, onshore and offshore non-hazardous, oilfield waste management and environmental cleaning services, including tank and vessel cleaning and safe vessel entry, for oil and gas companies operating in the Gulf of Mexico. For further information, visit the Company's web site at www.omnienergy.com.

Continue Reading

MondayNov 03, 2008 4:35 am

BELLUS Health, Inc. (NASDAQ: BLUS)

BELLUS Health, Inc. (NASDAQ: BLUS), a global health company, is committed to developing and commercializing products that provide innovative health solutions to address substantial, but unmet needs. The company’s wholly owned subsidiary, OVOS Natural Health Inc., aims to develop a strong franchise with several products marketed to help brain function as well as expand to other conditions. For further information, visit the Company's web site at www.bellushealth.com.

Continue Reading

MondayNov 03, 2008 4:34 am

Bartronics India Limited (NSE: BARTRONICS)

Bartronics India Limited (NSE: BARTRONICS) is focused on providing businesses the ability to gain real-time visibility and information by utilizing the implementation, integration and support of Automatic Identification & Data Capture (AIDC) technologies, RFID, Smart Cards and Point of Sale (POS) solutions. Recognized as a dominant player in the domestic markets, the company has engaged in exclusive relationships with many of the leading vendors worldwide. For further information, visit the Company's web site at www.bartronicsindia.com.

Continue Reading

MondayNov 03, 2008 4:33 am

Bayswater Uranium Corp. (TSX: ABAY CN)

Bayswater Uranium Corp. (TSX: BAY CN), a rapidly-growing international uranium exploration and development company, is the only uranium company to have major landholdings in each of Canada's most important producing and exploration regions -- the Athabasca Basin, the Central Mineral Belt, and the Thelon Basin. Additionally, the Company owns multiple advanced uranium properties in the United States that are being fast tracked to production. For further information, visit the Company's web site at www.bayswateruranium.com.

Continue Reading

MondayNov 03, 2008 4:33 am

Avigen, Inc. (NASDAQ: AVGN)

Avigen, Inc. (NASDAQ: AVGN), a biopharmaceutical company, engages in the development and commercialization of small molecule therapeutics designed to treat serious neurological disorders, including neuropathic pain and opioid addiction and withdrawal. The company’s strategic aim is to complete the requirements of clinical development for each of the candidates in its product pipeline, while seeking opportunities to expand its pipeline through internal research, acquisitions, and in-licensing. For further information, visit the Company's web site at www.avigen.com.

Continue Reading

MondayNov 03, 2008 4:32 am

AVI BioPharma, Inc. (NASDAQ: AVII)

AVI BioPharma, Inc. (NASDAQ: AVII) is committed to discovering and developing RNA-based drugs using its expanded portfolio of proprietary antisense compounds. Functional attributes of their unique approach may include correcting genetic defects, coding for novel soluble receptors, and the reduction in activity of immune modulators in disease states. Additionally, the company’s RNA-based drug programs include blocking mRNA translation. For further information, visit the Company's web site at www.avibio.com.

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

480-374-1336

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .